[Federal Register Volume 67, Number 102 (Tuesday, May 28, 2002)]
[Notices]
[Pages 36878-36879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-13344]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[OPPT-2002-0020; FRL-7181-9]


Endocrine Disruptor Method Validation Subcommittee under the 
National Advisory Council for Environmental Policy and Technology; 
Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: There will be a meeting, via teleconference, of the Endocrine 
Disruptor Methods Validation Subcommittee (EDMVS), a subcommittee under 
the National Advisory Council for Environmental Policy and Technology 
(NACEPT), a Federal Advisory Committee, on June 11, 2002, to discuss 
the steroidogenesis detailed review paper. The meeting is open to the 
public. Due to limited phone lines, we encourage all local participants 
to join us at RESOLVE. Seating will be on a first-come basis. The EDMVS 
meeting originally scheduled for June 10-12, 2002, has been postponed. 
That meeting will be rescheduled for late July.

DATES: The teleconference will be held on June 11, 2002, from 10 a.m. 
to noon (eastern daylight time). Requests to participate and make 
public comment in the meeting must be received on or before June 6, 
2002.

ADDRESSES: The teleconference will originate at RESOLVE, 1255 23rd St., 
NW., Suite 275, Washington, DC.

FOR FURTHER INFORMATION CONTACT: Jane Smith, Designated Federal 
Official, Office of Science Coordination and Policy (7201), 
Environmental Protection Agency, 1200 Pennsylvania Ave., NW., 
Washington, DC 20460; telephone number: (202) 564-8476; fax number: 
(202) 564-8483; e-mail address: [email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general. This action may, 
however, potentially affect you if you produce, manufacture, use, 
consume, work with, or import pesticide chemical substances that may 
have an effect cumulative to an effect of a pesticide, or substances 
found in sources of drinking water. To determine whether you or your 
business may be affected by this notice you should carefully examine 
section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA), as 
amended by the Food Quality Protection Act of 1996 (Public Law 104-
170), 21 U.S.C. 346A(p), and amendments to The Safe Drinking Water Act 
(Public Law 104-182), 42 U.S.C. 300j-17. Since other entities may also 
be interested, the Agency has not attempted to describe all the 
specific entities that may be affected by this action. If you have any 
questions regarding the applicability of this action to a particular 
entity, consult the person listed under FOR FURTHER INFORMATION 
CONTACT.

B. How Can I Get Additional Information, Including Copies of the 
Document and Other Related Documents?

    1. Electronically. You may obtain electronic copies of this 
document, and certain other related documents that might be available 
electronically, from the EPA Internet Home Page at http://www.epa.gov/. 
To access this document, on the Home Page search for ``Endocrine 
Disruptor'' which will take you to the OSCP Endocrine Disruptor web 
site. You can also look up the entry for this document under the 
Federal Register--Environmental Documents. You can also go directly to 
the Federal Register listings at http://www.epa.gov/fedrgstr/.
    A meeting agenda, a list of EDMVS members and information from 
previous meetings is available electronically, from the EPA Internet 
Home Page at http://www.epa.gov/scipoly/oscpendo.
    2. In person. The Agency has established an official record for 
this meeting under docket ID number OPPT-2002-0020. The official record 
consists of the documents specifically referenced in this notice, any 
public comments received during an applicable comment period, and other 
information related to Endocrine Disruptor Method Validation, including 
any information claimed as Confidential Business Information (CBI). The 
public version of the official record is available for inspection in 
the TSCA Nonconfidential Information Center, North East Mall, Rm. B-
607, Waterside Mall, 401 M St., SW., Washington, DC. The Center is open 
from noon to 4 p.m., Monday through Friday, excluding legal holidays. 
The telephone number of the Center is (202) 260-7099.

C. How Can I Request to Participate in this Meeting?

    In accordance with the Federal Advisory Committee Act (FACA), the 
public is encouraged to submit written comments on this detailed review 
paper. The EDMVS will have a brief period (no more than 15 minutes) 
available during the teleconference for public comment. It is the 
policy of the

[[Page 36879]]

EDMVS to accept written public comments of any length, and to 
accommodate oral public comments whenever possible. The EDMVS expects 
that public statements presented at its meetings will be on the meeting 
topic and not be repetitive of previously submitted oral or written 
statements.
    You may submit a request to participate in the meeting by e-mail, 
telephone, fax, or in person. We would normally accept requests by 
mail, but in this time of delays in delivery of government mail due to 
health and security concerns, we cannot assure your request would 
arrive in a timely manner. Do not submit any information in your 
request that is considered CBI. Your request must be received by EPA on 
or before June 6, 2002. To ensure proper receipt by EPA, it is 
imperative that you identify docket ID number OPPT-2002-0020 in the 
subject line on the first page of your request.
    1. Electronically. You may submit your request electronically by e-
mail to Jane Smith at: [email protected] or to the docket at: 
[email protected]. Do not submit any information electronically that 
you consider to be CBI. Use WordPerfect 6.1/8.0 or ASCII file format 
and avoid the use of special characters and any form of encryption. Be 
sure to identify by docket ID number OPPT-2000-0020. You may also file 
a request online at many Federal Depository Libraries.
    2. By telephone or fax. Contact Jane Smith, by telephone at (202) 
564-8476 or by fax number at (202) 564-8483.
    3. In person or by courier. You may deliver a request to: OPPT 
Docket Control Office, North East Mall, Rm. B-607, Waterside Mall, 401 
M St., SW., Washington, DC. The Docket Office is open from noon to 4 
p.m., Monday through Friday, excluding legal holidays. The telephone 
number of the Office is (202) 260-7099.

II. Background

    In 1996, through enactment of the Food Quality Protection Act, 
which amended the Federal Food, Drug, and Cosmetic Act, Congress 
directed EPA to develop a screening program to determine whether 
certain substances may have hormonal effects in humans. EPA formed a 
scientific advisory committee, the Endocrine Disruptor Screening and 
Testing Advisory Committee (EDSTAC), under FACA to advise it on 
establishing a program to carry out the Congressional directive. EDSTAC 
recommended a multi-step approach including a series of screens (Tier I 
Screens), and tests (Tier II Tests), because there were no validated 
test systems for determining whether a chemical may be an endocrine 
disruptor. To ensure that EPA has the best and most up-to-date advice 
available regarding the validation of the screens and tests for the 
EDSP, EPA recently created the Endocrine Disruptor Methods Validation 
Subcommittee (EDMVS) of the National Advisory Council for Environmental 
Policy and Technology (NACEPT). EDMVS, a group of subject-matter 
experts, provides independent advice and counsel to the Agency through 
NACEPT, on scientific and technical issues related to validation of the 
EDSP Tier I screens and Tier II tests, including advice on methods for 
reducing animal use, refining procedures involving animals to make them 
less stressful, and replacing animals where scientifically appropriate. 
More information is available on the website: http://www.epa.gov/scipoly/oscpendo.

List of Subjects

    Environmental protection, Endocrine disruptor screening program, 
Endocrine disruptors.


    Dated: May 23, 2002.
Andy Privee,
Acting Director, Office of Science Coordination and Policy.
[FR Doc. 02-13344 Filed 5-24-02; 8:45 am]
BILLING CODE 6560-50-S